APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Injectable

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Contraceptive Injectable Industry Growth and Trends Forecast to 2032

20 December 202592 pages

Choose your research edition.

Industry ResearchContraceptive Injectable Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Injectable Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Contraceptive Injectable Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Injectable Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Injectable Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Contraceptive Injectable market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Contraceptive Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Contraceptive Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Contraceptive Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Contraceptive Injectable include Janssen Pharmaceuticals, Inc., Pfizer Inc., China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), Bayer AG, Veru, Inc., Organon Group Of Companies, Church & Dwight, Agile Therapeutics and Afaxys, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Contraceptive Injectable market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Contraceptive Injectable market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Contraceptive Injectable market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Contraceptive Injectable.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Contraceptive Injectable market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Contraceptive Injectable Market by Company

Janssen Pharmaceuticals, Inc.

Pfizer Inc.

China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)

Bayer AG

Veru, Inc.

Organon Group Of Companies

Church & Dwight

Agile Therapeutics

Afaxys, Inc.

Contraceptive Injectable Segment by Type

Long-Acting Contraception

Short-Acting Contraception

Contraceptive Injectable Segment by Application

Male

Female

Contraceptive Injectable Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Injectable.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Contraceptive Injectable manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Contraceptive Injectable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Long-Acting Contraception Table 2. Major Company of Short-Acting Contraception Table 3. Global Contraceptive Injectable Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 5. Global Contraceptive Injectable Sales Market Share in Volume by Type (2021-2026) Table 6. Global Contraceptive Injectable Sales by Type (2021-2026) & (US$ Million) Table 7. Global Contraceptive Injectable Sales Market Share in Value by Type (2021-2026) Table 8. Global Contraceptive Injectable Price by Type (2021-2026) & (US$/unit) Table 9. Global Contraceptive Injectable Sales by Type (2027-2032) & (k units) Table 10. Global Contraceptive Injectable Sales Market Share in Volume by Type (2027-2032) Table 11. Global Contraceptive Injectable Sales by Type (2027-2032) & (US$ Million) Table 12. Global Contraceptive Injectable Sales Market Share in Value by Type (2027-2032) Table 13. Global Contraceptive Injectable Price by Type (2027-2032) & (US$/unit) Table 14. North America Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 15. North America Contraceptive Injectable Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 17. Europe Contraceptive Injectable Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Contraceptive Injectable Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 21. Latin America Contraceptive Injectable Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Contraceptive Injectable Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Contraceptive Injectable Sales by Type (2021-2026) & (US$ Million) Table 24. Contraceptive Injectable Industry Trends Table 25. Contraceptive Injectable Industry Drivers Table 26. Contraceptive Injectable Industry Opportunities and Challenges Table 27. Contraceptive Injectable Industry Restraints Table 28. Global Contraceptive Injectable Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Contraceptive Injectable Revenue Market Share by Company (2021-2026) Table 30. Global Contraceptive Injectable Sales by Company (2021-2026) & (k units) Table 31. Global Contraceptive Injectable Sales Share by Company (2021-2026) Table 32. Global Contraceptive Injectable Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Contraceptive Injectable Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Contraceptive Injectable Major Company Production Sites and Headquarters Table 35. Global Contraceptive Injectable Company, Product Type & Application Table 36. Global Contraceptive Injectable Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Contraceptive Injectable by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Contraceptive Injectable Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Contraceptive Injectable Sales by Region (2021-2026) & (k units) Table 41. Global Contraceptive Injectable Sales Market Share in Volume by Region (2021-2026) Table 42. Global Contraceptive Injectable Sales by Region (2021-2026) & (US$ Million) Table 43. Global Contraceptive Injectable Sales Market Share in Value by Region (2021-2026) Table 44. Global Contraceptive Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Contraceptive Injectable Sales by Region (2027-2032) & (k units) Table 46. Global Contraceptive Injectable Sales Market Share in Volume by Region (2027-2032) Table 47. Global Contraceptive Injectable Sales by Region (2027-2032) & (US$ Million) Table 48. Global Contraceptive Injectable Sales Market Share in Value by Region (2027-2032) Table 49. Global Contraceptive Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Contraceptive Injectable Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 52. Global Contraceptive Injectable Sales Market Share in Volume by Application (2021-2026) Table 53. Global Contraceptive Injectable Sales by Application (2021-2026) & (US$ Million) Table 54. Global Contraceptive Injectable Sales Market Share in Value by Application (2021-2026) Table 55. Global Contraceptive Injectable Price by Application (2021-2026) & (US$/unit) Table 56. Global Contraceptive Injectable Sales by Application (2027-2032) & (k units) Table 57. Global Contraceptive Injectable Sales Market Share in Volume by Application (2027-2032) Table 58. Global Contraceptive Injectable Sales by Application (2027-2032) & (US$ Million) Table 59. Global Contraceptive Injectable Sales Market Share in Value by Application (2027-2032) Table 60. Global Contraceptive Injectable Price by Application (2027-2032) & (US$/unit) Table 61. North America Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 62. North America Contraceptive Injectable Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 64. Europe Contraceptive Injectable Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Contraceptive Injectable Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 68. Latin America Contraceptive Injectable Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Contraceptive Injectable Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Contraceptive Injectable Sales by Application (2021-2026) & (US$ Million) Table 71. Janssen Pharmaceuticals, Inc. Company Information Table 72. Janssen Pharmaceuticals, Inc. Business Overview Table 73. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolio Table 75. Janssen Pharmaceuticals, Inc. Recent Development Table 76. Pfizer Inc. Company Information Table 77. Pfizer Inc. Business Overview Table 78. Pfizer Inc. Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Pfizer Inc. Contraceptive Injectable Product Portfolio Table 80. Pfizer Inc. Recent Development Table 81. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information Table 82. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Business Overview Table 83. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolio Table 85. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Development Table 86. Bayer AG Company Information Table 87. Bayer AG Business Overview Table 88. Bayer AG Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Bayer AG Contraceptive Injectable Product Portfolio Table 90. Bayer AG Recent Development Table 91. Veru, Inc. Company Information Table 92. Veru, Inc. Business Overview Table 93. Veru, Inc. Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Veru, Inc. Contraceptive Injectable Product Portfolio Table 95. Veru, Inc. Recent Development Table 96. Organon Group Of Companies Company Information Table 97. Organon Group Of Companies Business Overview Table 98. Organon Group Of Companies Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Organon Group Of Companies Contraceptive Injectable Product Portfolio Table 100. Organon Group Of Companies Recent Development Table 101. Church & Dwight Company Information Table 102. Church & Dwight Business Overview Table 103. Church & Dwight Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Church & Dwight Contraceptive Injectable Product Portfolio Table 105. Church & Dwight Recent Development Table 106. Agile Therapeutics Company Information Table 107. Agile Therapeutics Business Overview Table 108. Agile Therapeutics Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Agile Therapeutics Contraceptive Injectable Product Portfolio Table 110. Agile Therapeutics Recent Development Table 111. Afaxys, Inc. Company Information Table 112. Afaxys, Inc. Business Overview Table 113. Afaxys, Inc. Contraceptive Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Afaxys, Inc. Contraceptive Injectable Product Portfolio Table 115. Afaxys, Inc. Recent Development Table 116. North America Contraceptive Injectable Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 118. North America Contraceptive Injectable Sales Market Share by Country (2021-2026) Table 119. North America Contraceptive Injectable Sales Forecast by Country (2027-2032) & (k units) Table 120. North America Contraceptive Injectable Sales Market Share Forecast by Country (2027-2032) Table 121. North America Contraceptive Injectable Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Contraceptive Injectable Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Contraceptive Injectable Market Share by Country (2021-2026) Table 124. North America Contraceptive Injectable Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Contraceptive Injectable Market Share Forecast by Country (2027-2032) Table 126. Europe Contraceptive Injectable Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 128. Europe Contraceptive Injectable Sales Market Share by Country (2021-2026) Table 129. Europe Contraceptive Injectable Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe Contraceptive Injectable Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Contraceptive Injectable Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Contraceptive Injectable Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Contraceptive Injectable Market Share by Country (2021-2026) Table 134. Europe Contraceptive Injectable Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Contraceptive Injectable Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Contraceptive Injectable Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific Contraceptive Injectable Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Contraceptive Injectable Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific Contraceptive Injectable Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Contraceptive Injectable Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Contraceptive Injectable Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Contraceptive Injectable Market Share by Country (2021-2026) Table 144. Asia-Pacific Contraceptive Injectable Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Contraceptive Injectable Market Share Forecast by Country (2027-2032) Table 146. Latin America Contraceptive Injectable Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 148. Latin America Contraceptive Injectable Sales Market Share by Country (2021-2026) Table 149. Latin America Contraceptive Injectable Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America Contraceptive Injectable Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Contraceptive Injectable Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Contraceptive Injectable Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Contraceptive Injectable Market Share by Country (2021-2026) Table 154. Latin America Contraceptive Injectable Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Contraceptive Injectable Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Contraceptive Injectable Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa Contraceptive Injectable Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Contraceptive Injectable Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa Contraceptive Injectable Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Contraceptive Injectable Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Contraceptive Injectable Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Contraceptive Injectable Market Share by Country (2021-2026) Table 164. Middle East and Africa Contraceptive Injectable Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Contraceptive Injectable Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Contraceptive Injectable Distributors List Table 169. Contraceptive Injectable Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Contraceptive Injectable Image Figure 2. Global Contraceptive Injectable Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptive Injectable Market Size (2021-2032) & (US$ Million) Figure 4. Global Contraceptive Injectable Sales (2021-2032) & (k units) Figure 5. Long-Acting Contraception Image Figure 6. Global Long-Acting Contraception Sales YoY Growth (2021-2032) & (k units) Figure 7. Short-Acting Contraception Image Figure 8. Global Short-Acting Contraception Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Contraceptive Injectable Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Contraceptive Injectable Market Share by Type 2025 VS 2032 Figure 11. North America Contraceptive Injectable Sales Market Share in Volume by Type in 2025 Figure 12. North America Contraceptive Injectable Sales Market Share in Value by Type in 2025 Figure 13. Europe Contraceptive Injectable Sales Market Share in Volume by Type in 2025 Figure 14. Europe Contraceptive Injectable Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Contraceptive Injectable Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Contraceptive Injectable Sales Market Share in Value by Type in 2025 Figure 17. Latin America Contraceptive Injectable Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Contraceptive Injectable Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Contraceptive Injectable Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Contraceptive Injectable Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Contraceptive Injectable Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Male Image Figure 24. Global Male Sales YoY Growth (2021-2032) & (k units) Figure 25. Female Image Figure 26. Global Female Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Contraceptive Injectable Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Contraceptive Injectable Market Share by Application 2025 VS 2032 Figure 29. North America Contraceptive Injectable Sales Market Share in Volume by Application in 2025 Figure 30. North America Contraceptive Injectable Sales Market Share in Value by Application in 2025 Figure 31. Europe Contraceptive Injectable Sales Market Share in Volume by Application in 2025 Figure 32. Europe Contraceptive Injectable Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Contraceptive Injectable Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Contraceptive Injectable Sales Market Share in Value by Application in 2025 Figure 35. Latin America Contraceptive Injectable Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Contraceptive Injectable Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Contraceptive Injectable Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Contraceptive Injectable Sales Market Share in Value by Application in 2025 Figure 39. North America Contraceptive Injectable Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Contraceptive Injectable Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Contraceptive Injectable Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Contraceptive Injectable Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Contraceptive Injectable Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Contraceptive Injectable Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Contraceptive Injectable Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Contraceptive Injectable Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Contraceptive Injectable Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Contraceptive Injectable Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Contraceptive Injectable Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Contraceptive Injectable Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Contraceptive Injectable Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Contraceptive Injectable Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Contraceptive Injectable Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Contraceptive Injectable Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Contraceptive Injectable Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Contraceptive Injectable Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Contraceptive Injectable Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Contraceptive Injectable Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Contraceptive Injectable Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Contraceptive Injectable Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Long-Acting Contraception
  • Short-Acting Contraception
Applications
  • Male
  • Female
Companies covered
  • Janssen Pharmaceuticals, Inc.
  • Pfizer Inc.
  • China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
  • Bayer AG
  • Veru, Inc.
  • Organon Group Of Companies
  • Church & Dwight
  • Agile Therapeutics
  • Afaxys, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Contraceptive Injectable Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Contraceptive Injectable Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Contraceptive Injectable Market by Type
  6. 1.3.1 Long-Acting Contraception
  7. 1.3.2 Short-Acting Contraception
  8. 1.4 Global Contraceptive Injectable Market Size by Type
  9. 1.4.1 Global Contraceptive Injectable Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Contraceptive Injectable Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Contraceptive Injectable Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Contraceptive Injectable Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Contraceptive Injectable Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Contraceptive Injectable Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Contraceptive Injectable Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Contraceptive Injectable Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Contraceptive Injectable Industry Trends
  2. 2.2 Contraceptive Injectable Industry Drivers
  3. 2.3 Contraceptive Injectable Industry Opportunities and Challenges
  4. 2.4 Contraceptive Injectable Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Contraceptive Injectable Revenue (2021-2026)
  2. 3.2 Global Top Players by Contraceptive Injectable Sales (2021-2026)
  3. 3.3 Global Top Players by Contraceptive Injectable Price (2021-2026)
  4. 3.4 Global Contraceptive Injectable Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Contraceptive Injectable Major Company Production Sites & Headquarters
  6. 3.6 Global Contraceptive Injectable Company, Product Type & Application
  7. 3.7 Global Contraceptive Injectable Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Contraceptive Injectable Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Contraceptive Injectable Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Contraceptive Injectable Tier 1, Tier 2, and Tier 3
4 Contraceptive Injectable Regional Status and Outlook
  1. 4.1 Global Contraceptive Injectable Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Contraceptive Injectable Historic Market Size by Region
  3. 4.2.1 Global Contraceptive Injectable Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Contraceptive Injectable Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Contraceptive Injectable Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Contraceptive Injectable Forecasted Market Size by Region
  7. 4.3.1 Global Contraceptive Injectable Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Contraceptive Injectable Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Contraceptive Injectable Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Contraceptive Injectable by Application
  1. 5.1 Contraceptive Injectable Market by Application
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Contraceptive Injectable Market Size by Application
  5. 5.2.1 Global Contraceptive Injectable Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Contraceptive Injectable Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Contraceptive Injectable Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Contraceptive Injectable Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Contraceptive Injectable Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Contraceptive Injectable Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Contraceptive Injectable Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Contraceptive Injectable Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Janssen Pharmaceuticals, Inc.
  2. 6.1.1 Janssen Pharmaceuticals, Inc. Company Information
  3. 6.1.2 Janssen Pharmaceuticals, Inc. Business Overview
  4. 6.1.3 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolio
  6. 6.1.5 Janssen Pharmaceuticals, Inc. Recent Developments
  7. 6.2 Pfizer Inc.
  8. 6.2.1 Pfizer Inc. Company Information
  9. 6.2.2 Pfizer Inc. Business Overview
  10. 6.2.3 Pfizer Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Inc. Contraceptive Injectable Product Portfolio
  12. 6.2.5 Pfizer Inc. Recent Developments
  13. 6.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
  14. 6.3.1 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information
  15. 6.3.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Business Overview
  16. 6.3.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolio
  18. 6.3.5 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Developments
  19. 6.4 Bayer AG
  20. 6.4.1 Bayer AG Company Information
  21. 6.4.2 Bayer AG Business Overview
  22. 6.4.3 Bayer AG Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer AG Contraceptive Injectable Product Portfolio
  24. 6.4.5 Bayer AG Recent Developments
  25. 6.5 Veru, Inc.
  26. 6.5.1 Veru, Inc. Company Information
  27. 6.5.2 Veru, Inc. Business Overview
  28. 6.5.3 Veru, Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Veru, Inc. Contraceptive Injectable Product Portfolio
  30. 6.5.5 Veru, Inc. Recent Developments
  31. 6.6 Organon Group Of Companies
  32. 6.6.1 Organon Group Of Companies Company Information
  33. 6.6.2 Organon Group Of Companies Business Overview
  34. 6.6.3 Organon Group Of Companies Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Organon Group Of Companies Contraceptive Injectable Product Portfolio
  36. 6.6.5 Organon Group Of Companies Recent Developments
  37. 6.7 Church & Dwight
  38. 6.7.1 Church & Dwight Company Information
  39. 6.7.2 Church & Dwight Business Overview
  40. 6.7.3 Church & Dwight Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Church & Dwight Contraceptive Injectable Product Portfolio
  42. 6.7.5 Church & Dwight Recent Developments
  43. 6.8 Agile Therapeutics
  44. 6.8.1 Agile Therapeutics Company Information
  45. 6.8.2 Agile Therapeutics Business Overview
  46. 6.8.3 Agile Therapeutics Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Agile Therapeutics Contraceptive Injectable Product Portfolio
  48. 6.8.5 Agile Therapeutics Recent Developments
  49. 6.9 Afaxys, Inc.
  50. 6.9.1 Afaxys, Inc. Company Information
  51. 6.9.2 Afaxys, Inc. Business Overview
  52. 6.9.3 Afaxys, Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Afaxys, Inc. Contraceptive Injectable Product Portfolio
  54. 6.9.5 Afaxys, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Contraceptive Injectable Sales by Country
  2. 7.1.1 North America Contraceptive Injectable Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Contraceptive Injectable Sales by Country (2021-2026)
  4. 7.1.3 North America Contraceptive Injectable Sales Forecast by Country (2027-2032)
  5. 7.2 North America Contraceptive Injectable Market Size by Country
  6. 7.2.1 North America Contraceptive Injectable Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Contraceptive Injectable Market Size by Country (2021-2026)
  8. 7.2.3 North America Contraceptive Injectable Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Contraceptive Injectable Sales by Country
  2. 8.1.1 Europe Contraceptive Injectable Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Contraceptive Injectable Sales by Country (2021-2026)
  4. 8.1.3 Europe Contraceptive Injectable Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Contraceptive Injectable Market Size by Country
  6. 8.2.1 Europe Contraceptive Injectable Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Contraceptive Injectable Market Size by Country (2021-2026)
  8. 8.2.3 Europe Contraceptive Injectable Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Contraceptive Injectable Sales by Country
  2. 9.1.1 Asia-Pacific Contraceptive Injectable Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Contraceptive Injectable Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Contraceptive Injectable Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Contraceptive Injectable Market Size by Country
  6. 9.2.1 Asia-Pacific Contraceptive Injectable Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Contraceptive Injectable Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Contraceptive Injectable Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Contraceptive Injectable Sales by Country
  2. 10.1.1 South America Contraceptive Injectable Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Contraceptive Injectable Sales by Country (2021-2026)
  4. 10.1.3 South America Contraceptive Injectable Sales Forecast by Country (2027-2032)
  5. 10.2 South America Contraceptive Injectable Market Size by Country
  6. 10.2.1 South America Contraceptive Injectable Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Contraceptive Injectable Market Size by Country (2021-2026)
  8. 10.2.3 South America Contraceptive Injectable Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Contraceptive Injectable Sales by Country
  2. 11.1.1 Middle East and Africa Contraceptive Injectable Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Contraceptive Injectable Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Contraceptive Injectable Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Contraceptive Injectable Market Size by Country
  6. 11.2.1 Middle East and Africa Contraceptive Injectable Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Contraceptive Injectable Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Contraceptive Injectable Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Contraceptive Injectable Value Chain Analysis
  2. 12.1.1 Contraceptive Injectable Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Contraceptive Injectable Production Mode & Process
  7. 12.2 Contraceptive Injectable Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Contraceptive Injectable Distributors
  10. 12.2.3 Contraceptive Injectable Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst